n-methylscopolamine has been researched along with butylscopolammonium bromide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baissat, J; Chassaing, C; Duchêne-Marullaz, P; Dureng, G | 1 |
| Bertellotti, L; Boraschi, P; Braccini, G; Marraccini, P; Marrucci, A; Testa, R | 1 |
1 trial(s) available for n-methylscopolamine and butylscopolammonium bromide
| Article | Year |
|---|---|
[Usefulness of pirenzepine in the study of the upper digestive tract and the large intestine with double contrast media: comparison with scopolamine methylbromide].
Topics: Adult; Aged; Aged, 80 and over; Butylscopolammonium Bromide; Contrast Media; Female; Gastrointestinal Diseases; Heart Rate; Humans; Male; Middle Aged; Muscarinic Antagonists; N-Methylscopolamine; Pirenzepine; Radiography; Scopolamine Derivatives; Single-Blind Method | 1996 |
1 other study(ies) available for n-methylscopolamine and butylscopolammonium bromide
| Article | Year |
|---|---|
Pharmacological evidence for cardiac muscarinic receptor subtypes.
Topics: Acetylcholine; Animals; Arecoline; Atropine; Benzodiazepinones; Binding Sites; Butylscopolammonium Bromide; Carbachol; Female; Guinea Pigs; Heart Rate; Male; Myocardial Contraction; Myocardium; N-Methylscopolamine; Pirenzepine; Quaternary Ammonium Compounds; Receptors, Muscarinic; Scopolamine Derivatives | 1984 |